← Leaderboards
Leah M Backhus
Veterans Admin Palo Alto Health Care Sys
$973,152
Attributed
$1,946,303
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $649.7K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,946,303 · 1
VA$0 · 1
By mechanism
R01$1,946,303 · 1
I01$0 · 1
Top collaborators
- Joseph B Shrager9 shared
Most similar at Veterans Admin Palo Alto Health Care Sys
Same institution · by research overlap
- Joseph B Shrager$2,276,071
- Alex Sox-Harris$1,488,939
Others in their field
Other Emerging Leaders on “Randomized”
- Beth Baseler · Leidos Biomedical Research, Inc.$194,920,310
- Susan Abushakra · Alzheon, Inc.$50,765,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$36,614,885
- Abraham Aizer Brody · New York University School Of Medicine$23,359,458
- Yunda Huang · Fred Hutchinson Cancer Center$19,033,873
Research focus
RandomizedInstitutionCohortBaseMuscle WeaknessPlacebosPreventAtrophicFirst-In-HumanHourLeadMuscle FibersPathway InteractionsPharmaceutical PreparationsBreathingAnimalsBiopsyClinical TrialsCessation Of LifeEsophagectomyFunctional DisorderDependenceEtiologyIntensive Care Units
Grant awards (16)
Imaging Surveillance After Lung Cancer Treatment$0
I01 · FY2025 · VA · contact PI
Imaging Surveillance After Lung Cancer Treatment$0
I01 · FY2024 · VA · contact PI
Imaging Surveillance After Lung Cancer Treatment$0
I01 · FY2023 · VA · contact PI
A Mechanistic Clinical Trial of JAK Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction$391,250
R01 · FY2022 · HL
A Mechanistic Clinical Trial of JAK Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction$113,221
R01 · FY2022 · HL
A Mechanistic Clinical Trial of JAK Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction$9,609
R01 · FY2022 · HL
Imaging Surveillance After Lung Cancer Treatment$0
I01 · FY2022 · VA · contact PI
A Mechanistic Clinical Trial of JAK Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction$391,250
R01 · FY2021 · HL
A Mechanistic Clinical Trial of JAK Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction$115,357
R01 · FY2021 · HL
A Mechanistic Clinical Trial of JAK Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction$104,609
R01 · FY2021 · HL
A Mechanistic Clinical Trial of JAK Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction$38,507
R01 · FY2021 · HL
Imaging Surveillance After Lung Cancer Treatment$0
I01 · FY2021 · VA · contact PI
A Mechanistic Clinical Trial of JAK Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction$391,250
R01 · FY2020 · HL
Imaging Surveillance After Lung Cancer Treatment$0
I01 · FY2020 · VA · contact PI
A Mechanistic Clinical Trial of JAK Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction$391,250
R01 · FY2019 · HL
Imaging Surveillance After Lung Cancer Treatment$0
I01 · FY2019 · VA · contact PI